Abstract

P 008

Combined cataract-glaucoma surgery using the intracanalicular Eyepass glaucoma implant: First clinical results of a prospective pilot study

Dietlein T. S., Konen W., Lüke C., Jordan J., Schild A., Krieglstein G. K. 
Department of Ophthalmology, University Cologne, Köln

Objective: After conjunctival dissection, scleral flap dissection and identification of Schlemm's canal the y-shaped Eyepass glaucoma implant (GMP) is inserted with its ends into the lumina of Schlemm's canal and into the peripheral anterior chamber. The aim of our prospective pilot study was to investigate the safety and the pressure reducing efficacy of this implant in combined cataract-glaucoma surgery.
Methods: In 10 patients with primary open-angle or exfoliative glaucoma and cataract we performed phaco with a foldable lens and implantation of an Eyepass implant. Perioperative complications, intraocular pressure (IOP) values and local medications (LM) were monitored during the preliminary mean follow-up of 6 (1-12) months.
Results: The mean preoperative maximum IOP was 30±8 (21-46) mmHg, 12±6 (2-20) mmHg at day 1 postop., 17±4 (12-27) mmHg at 4 weeks postop and 17±4 (12-25) mmHg at the end of mean preliminary follow-up. The mean number of LM was 3.2±0.8 preoperatively and 0.8±0.8 at the end of follow-up. No major complications that required surgical revision were observed.
Conclusions: Combined surgery with the Eyepass implant is a safe surgical procedure. This procedure has a surgical concept comparable to trabeculotomy and seems to be a valuable option in glaucomatous eyes with cataract that do not require an extreme low target pressure.

Copyright: Porstmann Kongresse GmbH. All rights reserved. Impressum, Disclaimer.